| 22nd Dec 2020 7:00 am |
RNS |
Update on the recently acquired NTCD-M3 programme |
| 1st Dec 2020 5:23 pm |
RNS |
Holding(s) in Company |
| 30th Nov 2020 2:00 pm |
RNS |
Holding(s) in Company |
| 26th Nov 2020 10:50 am |
RNS |
Result of General Meeting and Total Voting Rights |
| 25th Nov 2020 7:00 am |
RNS |
Result of Open Offer |
| 9th Nov 2020 4:25 pm |
RNS |
Fundraising and Acquisition |
| 12th Oct 2020 7:00 am |
RNS |
Clinical Study Patient Recruitment Update |
| 17th Sep 2020 7:00 am |
RNS |
Interim results for the 6 months ended 30 Jun 2020 |
| 17th Sep 2020 7:00 am |
RNS |
Update on Phase 2b clinical study of XF-73 |
| 10th Sep 2020 7:00 am |
RNS |
Notice of Results |
| 7th Sep 2020 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 7th Sep 2020 4:35 pm |
RNS |
Price Monitoring Extension |
| 7th Sep 2020 2:06 pm |
RNS |
Second Price Monitoring Extn |
| 7th Sep 2020 2:01 pm |
RNS |
Price Monitoring Extension |
| 7th Sep 2020 11:06 am |
RNS |
Second Price Monitoring Extn |
| 7th Sep 2020 11:01 am |
RNS |
Price Monitoring Extension |
| 7th Sep 2020 9:05 am |
RNS |
Second Price Monitoring Extn |
| 7th Sep 2020 9:00 am |
RNS |
Price Monitoring Extension |
| 7th Sep 2020 7:00 am |
RNS |
Collaboration to co-develop treatment for COVID-19 |
| 11th Aug 2020 7:00 am |
RNS |
Positive interim safety review of XF-73 phase 2b |
| 27th Jul 2020 7:00 am |
RNS |
Update on Phase 2b clinical study of XF-73 |
| 15th Jul 2020 7:00 am |
RNS |
Destiny Pharma notes launch of AMR Action Fund |
| 19th Jun 2020 11:00 am |
RNS |
Cancellation and Grant of Options |
| 10th Jun 2020 12:30 pm |
RNS |
Result of AGM |
| 9th Jun 2020 7:00 am |
RNS |
Grant awarded for Cardiff University collaboration |
| 12th May 2020 3:15 pm |
RNS |
Posting of Annual Report and Notice of AGM |
| 4th May 2020 7:00 am |
RNS |
Independent review supports the potential of XF-73 |
| 29th Apr 2020 7:00 am |
RNS |
Final Results |
| 24th Apr 2020 7:00 am |
RNS |
Notice of Results |
| 3rd Mar 2020 7:00 am |
RNS |
Clinical and Business Update |
| 20th Jan 2020 7:00 am |
RNS |
Update on the development of XF drug formulations |
| 17th Dec 2019 7:00 am |
RNS |
APSIC guidelines recommend decolonising S. aureus |
| 2nd Dec 2019 7:00 am |
RNS |
Directorate Change |
| 2nd Dec 2019 7:00 am |
RNS |
Destiny to present at UK-China AMR Workshop |
| 15th Nov 2019 7:30 am |
RNS |
Presentation at the Investival Showcase |
| 6th Nov 2019 7:00 am |
RNS |
Destiny Pharma to present at World AMR Congress |
| 16th Oct 2019 7:00 am |
RNS |
Positive phase 1 results published in journal |
| 23rd Sep 2019 7:00 am |
RNS |
Directorate Change |
| 23rd Sep 2019 7:00 am |
RNS |
Interim Results for 6 months ended 30 June 2019 |
| 12th Sep 2019 7:00 am |
RNS |
Notice of Results |
